Tracking the CIRM: $134 Million, Including Two Clinical Trials and Community Care Centers, Plus Possibly an Interim CEO
Next week will be busy, busy, busy for the California stem cell agency, which will act on $134 million in programs and may name an interim president to keep the program on track while it tries to find a new CEO, a task that is likely to take many months.
The public can participate in all of the above meetings. Instructions are on the agendas, all of whic…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.